Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Quantum BioPharma's licensee, Unbuzzd Wellness Inc., has appointed Michael Zapolin as CEO with plans to finance and list the company on a stock exchange as well as execute a nationwide commercial marketing and product rollout in the U.S. Unbuzzd is a clinically validated beverage that accelerates alcohol metabolism, restores mental clarity, and red…
Trident Digital Tech Holdings Ltd announced that it has regained compliance with the Nasdaq minimum market value of listed securities requirement after its market value exceeded $35 million for 10 consecutive business days. This resolves the earlier deficiency notification received in March 2026, allowing the company to continue its listing on the …
SkyAI, Inc. acknowledges significant shareholder concerns reflected in the 2026 Annual Meeting voting results. The Board and management are committed to thoroughly engaging with shareholders and evaluating necessary actions related to capital allocation, corporate governance, strategic direction, and shareholder communications to reduce the company…
3 E Network Technology Group Limited announces a strategic partnership with HashBeaver to leverage a token-based Web3 payment gateway for its Finnish green AI compute center. This collaboration aims to broaden global market reach by enabling decentralized AI developers and communities to access compute resources via blockchain-based on-chain settle…
Nexentis Technologies Inc. has appointed Professor Dan T. Major to the Scientific Advisory Board of its wholly owned subsidiary, MitoCareX Bio Ltd. Prof. Major, an expert in computational chemistry and in silico drug discovery, will advise MitoCareX as it expands its computational drug discovery capabilities to enhance prioritization of its researc…
Sky Quarry Inc. announced the restart of its Eagle Springs Refinery in Nevada following approval of an air permit by the Nevada Division of Environmental Protection. The refinery, operated by Sky Quarry's subsidiary Foreland Refining Corporation, has a capacity of approximately 5,000 barrels per day. The company completed $300,000 in upgrades and p…
Immuneering Corporation announced that data from its ongoing Phase 3 MAPKeeper 301 trial evaluating atebimetinib in combination with chemotherapy for first-line treatment of metastatic pancreatic cancer will be presented at the ESMO Congress 2026. The trial investigates a novel Deep Cyclic Inhibitor designed to improve survival by shrinking tumors,…
Kala Bio and Virotek have signed a non-binding letter of intent with a U.S. DNA testing platform to resell Virotek's genetic testing products, potentially expanding distribution beyond ophthalmology and creating new commercial channels. The agreement is still subject to finalization of terms and definitive agreements. Kala anticipates this could ge…
Profusa, Inc. announced progress in its quality management certification under ISO 13485 through GMED, moving closer to obtaining MDR conformity assessment and CE marking for its Lumee Oxygen Platform, a biosensor technology for continuous tissue oxygen monitoring. This milestone reflects enhanced compliance with European medical device regulations…
Streamex Corp. announced that a leading institutional investment manager has launched a gold-denominated delta-neutral strategy using GLDY, its gold-backed tokenized asset, with an initial investment of $1 million. This marks a significant milestone as Streamex meets its ninety-day objective to convert institutional allocations into GLDY, potential…
TurboGen Ltd., a developer of combined heat and power systems based on multifuel microturbines, reported financial results for the first half of 2026, highlighting a $7.2 million cash position as of June 30, supplemented by a recent $5 million private placement. The company commenced Nasdaq trading in August 2026 and is preparing for initial instal…
Microchip Technology announced new 65V digital power monitor families PAC1761 and PAC1861 designed to support growing 48V power architectures across automotive, AI/data center, networking, and industrial sectors. These devices offer enhanced voltage measurement headroom, transient spike protection, and energy-aware real-time power insights to build…
Auddia Inc. (NASDAQ: AUUD) has adjourned its Special Meeting of Stockholders to October 7, 2026, to allow additional time for shareholders to vote on the proposed merger with Thramann Holdings. Currently, approximately 88% of votes cast support the merger, but a majority of all outstanding shares must approve the transaction. Upon completion, the c…
Ethan Allen Interiors Inc. filed its definitive proxy statement ahead of the November 4, 2026 Annual Meeting, urging shareholders to vote for its five highly qualified director nominees in response to a proxy contest instigated by 5.2% shareholder DGB Investment. The company highlights its strong five-year shareholder return of 49.1%, a debt-free b…
The Lovesac Company announced its participation in the 2026 Global Consumer & Retail Conference hosted by Telsey Advisory Group. The company will hold a fireside chat on October 8, 2026, which will be webcast live and available on the company's investor relations website. Lovesac is known for its modular furniture products focusing on innovation an…
Satellos Bioscience Inc. announced FDA clearance of its IND application to begin a Phase 2 clinical trial for forazapadin, a novel oral small molecule drug candidate aimed at muscle regeneration, targeting facioscapulohumeral muscular dystrophy (FSHD). The company secured up to $5 million in non-dilutive financing from the FSHD Canada Foundation to…
Tri Pointe Homes has acquired 60.4 acres in Bluffton, South Carolina to develop 76 single-family home sites as the final phase of the New Riverside mixed-use community. This strategic acquisition taps into one of the fastest-growing residential markets in the Southeast, with construction targeted to start in late 2027 and sales in 2028. The develop…
Vistagen announced positive exploratory findings from two clinical trials indicating that its lead product candidate, fasedienol nasal spray, shows potential efficacy in treating individuals with very severe social anxiety disorder. These findings include statistically significant improvements in anxiety symptoms during public speaking challenges a…
Ligand Pharmaceuticals has entered a financing agreement with AvenCell Therapeutics to provide up to $47 million to support clinical development of AvenCell's allogeneic CAR-T therapies targeting acute myeloid leukemia and B-cell malignancies. Ligand will receive royalties on the sales of AvenCell's pipeline assets, with funding released upon achie…
Mesoblast Limited has received FDA approval to implement the T-cell Proliferation Inhibition BioAssay (TIBA) for release and stability monitoring of its FDA-approved mesenchymal stromal cell product, Ryoncil. This new potency assay complements existing tests to ensure consistent potency and clinical effectiveness, supporting the commercial release …
X-Energy's subsidiary TRISO-X has completed vertical construction of TX-1, a cutting-edge nuclear fuel fabrication facility in Oak Ridge, Tennessee. This milestone enables progression to interior buildout and equipment installation, aiming to produce advanced TRISO nuclear fuel for multiple Xe-100 small modular reactors. The project benefits from r…
Pasqal Holding SA announced its first half 2026 financial results, highlighting 14% year-over-year revenue growth driven by a 34% increase in QPU-related services. The company advanced its quantum computing platform by scaling to over 1,000 physical qubits and expanding commercial partnerships with major players like NVIDIA, Google, and Saudi Aramc…
Cullinan Therapeutics, a clinical-stage biopharmaceutical company, announced key upcoming clinical data presentations in late 2026 for its T cell engager drug candidates targeting autoimmune diseases and cancer. Highlights include upcoming multi-dose regimen data for Velinotamig in SLE, CLN-978 in SLE, RA, and Sjögren’s disease, and updated Phase 1…
Descartes Systems Group launched the Descartes Datamyne AI Agent, a cutting-edge conversational AI integrated into its global trade intelligence platform. The AI Agent leverages over 500 million annual shipment records from 230 markets to help logistics, sourcing, sales, and supply chain teams reduce trade data research and analysis time by up to 9…
Ducommun Incorporated held its first Investor Day in four years, reporting strong progress against its VISION 2027 strategic plan and unveiling the VISION 2032 roadmap. The company aims to accelerate growth through expanded acquisitions, defense franchise expansion, commercial aerospace recovery, and investment in proprietary engineered products. I…
